We are glad to announce the launch of GELSECTAN® in Germany, Belgium and The Netherlands.
GELSECTAN® belongs to a new class of products defined as “mucosal protectors”, which helps to restore the normal function of the epithelial barrier in the gut. It is intended to relieve and prevent IBS symptoms such as chronic or relapsing diarrhea, pain and bloating.
GELSECTAN® is already marketed in Spain, Portugal and Greece. Other European countries, including Austria, Romania, Finland, Hungary and Italy will follow within the next few months.
GELSECTAN® is a class IIa medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments (CE 0476, Noventure SL). It is available in the Belgian market since September 2018.
In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.